OnKure Therapeutics, Inc. (OKUR)

Official site

HEALTHCARE • BIOTECHNOLOGY • NASDAQ

$2.13

-0.12 (-5.33%)

Market Cap: $91.12M

Last updated: Oct 16, 2026 at 1:55 PM ET

Earnings

Performance (10Y)

Beat Rate

75%(6/8)

Avg Surprise

-1.30%

Streak

1 Q

Upcoming Estimates

Period ending Sep 30, 2026

EPS Consensus$-0.41

Range$-0.62 - $-0.29

4 analysts

EPS Revisions

30d

EPS Estimate DriftChange to current

90d ago$-0.57+28.5%

60d ago$-0.57+28.5%

30d ago$-0.57+28.5%

7d ago$-0.47+11.8%

Current$-0.41

Revenue Consensus

$125000

Range$0 - $500000

4 analysts

Period ending Dec 31, 2026

EPS Consensus$-0.14

Range$-0.71 - $0.22

4 analysts

Revenue Consensus

$-125000

Range$-375000 - $625000

4 analysts

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Dec 31, 2026Dec 26EST	-	$-0.14	$-0.71 - $0.22	-	-	4	-	-
Sep 30, 2026Sep 26EST	-	$-0.41	$-0.62 - $-0.29	-	-	4	1 0 30d	-
Jun 30, 2026Jun 26 Reported Aug 4, 2026Reported Aug 4	$-0.31	$-0.58	$-0.77 - $-0.39	+46.55%	Beat	4	No revisions (30d)	+72.8%
Mar 31, 2026Mar 26 Reported May 5, 2026Reported May 5	$-1.11	$-0.74	$-1.05 - $-0.39	-50.00%	Miss	4	2 0 30d	+6.4%
Dec 31, 2025Dec 25 Reported Mar 12, 2026Reported Mar 12	$-0.99	$-1.15	$-1.25 - $-1.03	+14.06%	Beat	5	2 1 30d	+27.7%
Sep 30, 2025Sep 25 Reported Nov 6, 2025Reported Nov 6	$-1.09	$-1.20	$-1.22 - $-1.09	+9.17%	Beat	5	4 0 30d	-26.7%
Jun 30, 2025Jun 25 Reported Aug 12, 2025Reported Aug 12	$-1.14	$-1.25	-	+8.80%	Beat	-	-	+28.9%
Mar 31, 2025Mar 25 Reported May 6, 2025Reported May 6	$-1.19	$-1.38	$-1.54 - $-1.29	+14.04%	Beat	3	No revisions (30d)	+52.9%
Dec 31, 2024Dec 24 Reported Mar 10, 2025Reported Mar 10	$-1.37	$-0.87	$-1.10 - $-0.38	-57.47%	Miss	4	No revisions (30d)	+80.6%
Sep 30, 2024Sep 24 Reported Nov 7, 2024Reported Nov 7	$-0.86	$-0.90	-	+4.44%	Beat	-	-	+84.9%
Jun 30, 2024Jun 24 Reported Aug 13, 2024Reported Aug 13	$-1.60	N/A	-	N/A	Beat	-	-	+75.2%
Mar 31, 2024Mar 24 Reported May 7, 2024Reported May 7	$-2.52	N/A	-	N/A	Beat	-	-	+58.2%
Dec 31, 2023Dec 23 Reported Mar 28, 2024Reported Mar 28	$-7.05	N/A	-	N/A	Beat	-	-	-27.3%
Sep 30, 2023Sep 23 Reported Nov 13, 2023Reported Nov 13	$-5.68	N/A	-	N/A	Beat	-	-	-6.9%
Jun 30, 2023Jun 23 Reported Aug 10, 2023Reported Aug 10	$-6.46	N/A	-	N/A	Beat	-	-	-28.4%
Mar 31, 2023Mar 23 Reported May 11, 2023Reported May 11	$-6.03	N/A	-	N/A	Beat	-	-	-13.2%
Dec 31, 2022Dec 22 Reported Mar 27, 2023Reported Mar 27	$-5.54	N/A	-	N/A	Beat	-	-	-27.7%
Sep 30, 2022Sep 22 Reported Nov 8, 2022Reported Nov 8	$-5.31	N/A	-	N/A	Beat	-	-	-1.7%
Jun 30, 2022Jun 22 Reported Aug 9, 2022Reported Aug 9	$-5.03	N/A	-	N/A	Beat	-	-	-16.7%
Mar 31, 2022Mar 22 Reported May 11, 2022Reported May 11	$-5.33	N/A	-	N/A	Beat	-	-	-79.5%
Dec 31, 2021Dec 21 Reported Mar 24, 2022Reported Mar 24	$-4.34	N/A	-	N/A	Beat	-	-	-
Sep 30, 2021Sep 21 Reported Nov 12, 2021Reported Nov 12	$-5.22	N/A	-	N/A	Beat	-	-	-
Jun 30, 2021Jun 21 Reported Aug 11, 2021Reported Aug 11	$-4.31	N/A	-	N/A	Beat	-	-	-
Mar 31, 2021Mar 21 Reported May 20, 2021Reported May 20	$-2.97	N/A	-	N/A	Beat	-	-	-

Key Metrics

Valuation
P/E Ratio	-0.61	EV/EBITDA	N/A
Price/FCF	-2.22x	FCF Yield	-45.06%
Profitability
Profit Margin	0.00%	Operating Margin	0.00%
ROE	-46.90%	ROIC	N/A
Financial Health
Debt/Equity	0.00x	Interest Coverage	18.09x
Current Ratio	26.75x	Quick Ratio	26.75x
Trading Statistics
Beta	0.75	Avg Volume	405.84K
52-Week High	$5.38	52-Week Low	$2.13

Technical Indicators Dashboard

Moving Averages

SMA 10$2.39

SMA 20$2.62

SMA 50$3.26

SMA 200$3.64

EMA 10$2.39

EMA 20$2.60

EMA 50$3.09

EMA 200$3.50

MACD

Line: -0.29Signal: -0.28Hist: -0.01

ADX

ADX: 26.6+DI: 8.9-DI: 28.0

Aroon & PSAR

Aroon UpN/A

Aroon Down100.0

PSAR$2.42

Bollinger Bands

Upper Band$3.20

Lower Band$2.04

%B Position4418%(Upper)

Band Width0.08

RSI (14-Day)

Oversold

23.6

Momentum Oscillators

Stoch %K14.1

Stoch %D20.0

Williams %R-94.9

ROC (10d)-16.1%

Momentum-0.41

CCI (20d)-128.4

MFI (14d)29.1

Volatility Measures

ATR (14d)$0.22(10.1%)

StdDev (20d)0.29

Hist Vol60.1%(High)

Volume Flow

VWAP$2.17

OBV710.1K

AD Line8.6M

CMF (20d)-0.093

Volume Metrics

Avg Vol (20d)433.2K

Vol Ratio0.8x

VWMA (20d)$2.56

Pivot Points

R3$2.52

R2$2.45

R1$2.35

Pivot Point$2.28

S1$2.18

S2$2.11

S3$2.01

Advanced Oscillators

TSI-47.37

Ultimate Osc44.3

KST-275.15

Financial Data

Quarter	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Total Revenue	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Cost of Revenue	$0	$0	$202,000	$0	$0	$0	$419,000	$0	$0	$0	$291,000	$0
Gross Profit	$0	$0	$-202,000	$0	$0	$0	$-419,000	$0	$0	$0	$-291,000	$0

Operating Expenses	$16.90M	$15.62M	$14.13M	$15.50M	$16.32M	$17.00M	$18.70M	$11.51M	$14.34M	$9.83M	$-21,116,000	$20.89M
R&D	$12.61M	$11.71M	$10.72M	$11.91M	$12.61M	$13.01M	$14.36M	$10.12M	$10.75M	$8.57M	$-6,898,000	$13.62M
SG&A	$4.29M	$3.91M	$3.40M	$3.59M	$3.71M	$3.99M	$4.34M	$1.40M	$3.59M	$1.26M	$-14,218,000	$7.27M
Operating Income	$-16,899,000	$-15,615,000	$-14,125,000	$-15,501,000	$-16,324,000	$-17,000,000	$-18,700,000	$-11,512,000	$-14,343,000	$-9,831,000	$21.12M	$-20,888,000

Interest Income	$0	$0	$0	$0	$0	$0	$0	$0	$0	$295,000	$0	$0
Interest Expense	$-1,553,000	$-458,000	$0	$-802,000	$-934,000	$-1,075,000	$0	$44,000	$-204,000	$0	$2.59M	$0
Income Before Tax	$-15,346,000	$-15,157,000	$-13,503,000	$-14,699,000	$-15,390,000	$-15,925,000	$-17,442,000	$-11,556,000	$-14,139,000	$-9,536,000	$18.52M	$-19,196,000
Income Tax Expense	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0

Net Income	$-15,346,000	$-15,157,000	$-13,503,000	$-14,699,000	$-15,390,000	$-15,925,000	$-17,442,000	$-11,556,000	$-14,139,000	$-9,536,000	$18.52M	$-19,196,000

EBITDA	$-16,711,000	$-15,412,000	$-13,923,000	$-15,297,000	$-16,112,000	$-16,788,000	$-18,478,000	$-11,230,000	$-14,194,000	$-9,680,000	$25.10M	$-20,693,000
EBIT	$-16,899,000	$-15,615,000	$-14,125,000	$-15,501,000	$-16,324,000	$-17,000,000	$-18,700,000	$-11,512,000	$-14,343,000	$-9,831,000	$21.12M	$-19,196,000

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about OKUR

News

No news available

Company news will appear here when available

OKUR Valuation and Fair Value

P/E: -0.6x
P/FCF: -2.2x
P/B: 0.6x

See GNG's fair value

OKUR Profitability: Margins, ROIC and FCF

Operating margin: 0.0%
Net margin: 0.0%
ROE: -46.9%
FCF yield: -45.1%

OKUR Competitors

Company	Ticker
Insight Molecular Diagnostics Inc.	IMDX
Biomea Fusion Inc	BMEA
Anixa Biosciences Inc	ANIX
Immunic Inc	IMUX
Pmv Pharmaceuticals Inc	PMVP
Hyperfine Inc	HYPR
Rani Therapeutics Holdings Inc	RANI
Rallybio Corp	RLYB

Sector: Healthcare

OKUR Analyst Ratings

Consensus: Buy
Analysts: 6
Strong Buy: 0
Buy: 5
Hold: 1
Sell: 0
Strong Sell: 0

OKUR Bull Case vs Bear Case

Bull case

OKUR beat EPS estimates in 75.0% of its last 8 reported quarters.
83.3% of OKUR's analyst ratings are Buy or Strong Buy.

OKUR Earnings: Beat Rate and Next Report

Beat rate: 6 of 8 quarters (75.0%)
Average surprise: -1.3%
EPS estimate (fiscal period ending Sep 30, 2026): $-0.41
Estimate revisions (30 days, fiscal period ending Sep 30, 2026): 1 up, 0 down

Frequently Asked Questions About OKUR

Does OKUR pay dividends?

OnKure Therapeutics, Inc. (OKUR) does not currently pay a regular dividend.

What is OKUR's market cap?

OnKure Therapeutics, Inc. (OKUR) has a market capitalization of $91.12M with a current stock price of $2.13.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In

Earnings

Performance (10Y)

Upcoming Estimates

Key Metrics

Technical Indicators Dashboard

Moving Averages

MACD

ADX

Aroon & PSAR

Bollinger Bands

RSI (14-Day)

Momentum Oscillators

Volatility Measures

Volume Flow

Volume Metrics

Pivot Points

Advanced Oscillators

Financial Data

Related GNG Research

News

OKUR Valuation and Fair Value

OKUR Profitability: Margins, ROIC and FCF

OKUR Competitors

OKUR Analyst Ratings

OKUR Bull Case vs Bear Case

Bull case

OKUR Earnings: Beat Rate and Next Report

Frequently Asked Questions About OKUR

Related stocks

Get full access to GNG Research